实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (1): 77-80.doi: 10.3969/j.issn.1672-5069.2026.01.020

• 肝硬化 • 上一篇    下一篇

慢性乙型肝炎和乙型肝炎肝硬化患者糖代谢异常调查及其影响因素分析*

周慧芳, 张露, 戴雪娥, 闫伟   

  1. 200052 上海市 解放军海军特色医学中心检验科(周慧芳,戴雪娥,闫伟);南京医科大学第二附属医院检验科(张露)
  • 收稿日期:2025-03-10 出版日期:2026-01-10 发布日期:2026-02-04
  • 通讯作者: 闫伟,E-mail:k04fcw@163.com
  • 作者简介:周慧芳,女,37岁,大学本科,主管技师。E-mail:13671552109@163.com
  • 基金资助:
    *上海市科学技术委员会科研基金资助项目(编号:24SF1903603)

Prevalenceand impacting factors of abnormal glucose metabolism in patients with chronic hepatitis B and hepatitis B-induced liver cirrhosis

Zhou Huifang, Zhang Lu, Dai Xue'e, et al   

  1. Clinical Laboratory, Naval Medical Center,Shanghai 200052, China
  • Received:2025-03-10 Online:2026-01-10 Published:2026-02-04

摘要: 目的 探讨慢性乙型肝炎(CHB)和乙型肝炎肝硬化(LC)患者糖代谢异常发生率及其影响因素。方法 2021年10月~2024年10月我院收治的CHB患者329例和乙型肝炎LC患者258例,常规检测糖代谢指标,应用二元Logistic回归分析影响糖代谢异常的因素。结果 本组CHB和LC患者糖代谢异常发生率为54.2%,其中空腹血糖受损(IFG) 者22例(3.7%),糖耐量受损(IGT) 者136例(23.2%)和糖尿病(DM)者160例(27.3%);LC组IFG和IGT发生率分别为5.0%和23.6%,与CHB组的2.7%和22.8%相比,无显著性差异(P>0.05),而DM发生率为35.7%,显著高于CHB组的20.7%(P<0.05);318例糖代谢异常者年龄、体质指数(BMI)、饮酒、合并高血压、高脂血症和肝硬化占比分别为(51.2±13.6)岁、(25.8±3.4)kg/m2、40.3%、25.8%、21.4%和64.3%,均显著大于或高于269例糖代谢正常组【分别为(40.3±9.3)岁、(23.6±3.1)kg/m2、28.3%、14.9%、9.7%和34.2,P<0.05】;多因素Logistic回归分析显示,年龄、饮酒史、高血压、高脂血症和LC均是影响CHB和LC患者发生糖代谢异常的危险因素(P<0.05)。结论 CHB和LC患者糖代谢异常发生率较高,年龄大、有饮酒史、合并高血压、合并高脂血症和LC等为诱发因素,应予以重点关注,早期处理。

关键词: 肝硬化, 乙型肝炎, 空腹血糖受损, 糖耐量受损, 糖尿病, 影响因素

Abstract: Objective The aim of this study was to investigate prevalence and impacting factors of abnormal glucose metabolism in patients with chronic hepatitis B (CHB) and hepatitis B-induced liver cirrhosis (LC). Methods 329 patients with CHB and 258 patients with hepatitis B-induced LC were encountered in our hospital between October 2021 and October 2024, and clinical materials were collected routinely. Binary Logistic regression analysis was adopted to analyze the factors impacting abnormal glucose metabolism in patients with CHB and LC. Results Prevalence of abnormal glucose metabolism in our series was 54.2%, with impaired fasting glucose (IFG) of 3.7%, impaired glucose tolerance (IGT) of 23.2% and diabetes mellitus (DM) of 27.3%; incidence of IFG and IGT in patients with LC were 5.0% and 23.6%, both not significantly different as compared to 2.7% and 22.8% in those with CHB (P>0.05), while incidence of DM was 35.7%, much higher than 20.7%(P<0.05) in patients with CHB; ages, body mass index (BMI), percentages of alcohol abuse, concomitant blood hypertension, hyperlipidemia and LC in 318 patients with abnormal glucose metabolism were(51.2±13.6)yr, (25.8±3.4)kg/m2, 40.3%, 25.8%, 21.4% and 64.3%, all significantly greater or higher than [(40.3±9.3)yr, (23.6±3.1)kg/m2, 28.3%, 14.9%, 9.7% and 34.2, respectively, P<0.05] in 269 patients with normal glucose metabolism; binary Logistic regression analysis showed that age, alcohol abuse, blood hypertension, hyperlipidemia and LC were all the risk factors impacting glucose metabolism in patients with CHB and LC (P<0.05). Conclusion The incidence of abnormal glucose metabolism in patients with CHB and LC is high, and patients with old age, alcohol abuse, concomitant hypertension, hyperlipidemia and LC are susceptible, which should be carefully screened and managed.

Key words: Liver cirrhosis, Hepatitis B, Impaired fasting glucose, Impaired glucose tolerance, Diabetes mellitus, Influencing factors